Skip to main content
. 2017 Oct 27;7:14232. doi: 10.1038/s41598-017-14587-3

Table 1.

Biochemical parameters of gemfibrozil and vehicle-treated non-transplanted group.

Variable nHTX GEM-nHTX p
Albumine (g/l) 39.1 ± 0.3 34.6 ± 0.2 <0.001
Alkaline phosphatase (U/l) 33.2 ± 2.7 41.3 ± 5.6 0.221
GPT (U/l) 35.6 ± 1.6 34.4 ± 0.6 0.482
GOT (U/l) 57.6 ± 2.1 55.8 ± 2.1 0.544
Direct bilirubine (µmol/l) 0.6 ± 0.1 0.4 ± 0.1 0.19
Total bilirubine (µmol/l) 1.3 ± 0.2 0.7 ± 0.1 0.036
Total cholesterol (mmol/l) 2.2 ± 0.1 1.7 ± 0.1 0.024
CK (U/l) 162.5 ± 8.4 163 ± 6.2 0.962
Creatinine (µmol/l) 30.1 ± 1.7 20.5 ± 1.0 <0.001
HDL cholesterol (mmol/l) 2.0 ± 0.1 1.6 ± 0.1 0.004
LDL cholesterol (mmol/l) 0.4 ± 0.1 0.3 ± 0.1 0.039
LDH (U/l) 137.2 ± 16.7 137.5 ± 16.5 0.991
Triglyceride (mmol/l) 0.5 ± 0.1 1 ± 0.1 0.014
Carbamide (mmol/l) 5.4 ± 0.3 5.7 ± 0.3 0.697

The results of biochemical parameters of gemfibrozil- and vehicle-treated non-transplanted groups are shown. The following parameters were studied: albumine, alkaline phophatase, glutamate-pyruvate transaminase (GPT), glutamate oxaloacetate transaminase (GOT), direct and total bilirubine, total cholesterol, creatine kinase (CK), creatinine, high and low-density lipoprotein-cholesterol (HDL, LDL), lactate dehydrogenase (LDH), triglyceride and carbamide. Study groups: gemfibrozil-control group (GEM-nHTX), control-group (nHTX).